Biowatch

Prof. Kang Shin-Hyuk Honored by Korean Neurosurgical Society for AI-Powered 6-Minute Brain Tumor Diagnosis

Prof. Kang Shin-Hyuk Honored by Korean Neurosurgical Society for AI-Powered 6-Minute Brain Tumor Diagnosis

Korea University Anam Hospital announced on Oct. 22 that Professor Kang Shin-Hyuk of its Department of Neurosurgery received an academic award at the...
Keimyung University President Synn Ilhi Receives Jagiellonian University’s Highest-Honor Medal

Keimyung University President Synn Ilhi Receives Jagiellonian University’s Highest-Honor Medal

Keimyung University President Synn Ilhi has received the Plus Ratio Quam Vis medal, Jagiellonian University’s highest honor.
Kyungpook National University Hospital Team Wins Back-to-Back Awards at International Congress

Kyungpook National University Hospital Team Wins Back-to-Back Awards at International Congress

A research team led by Professor Yoon Jong-pil of the Department of Orthopedic Surgery at Kyungpook National University...
FDA Clears Trial for Next-Gen CAR-T Therapy That Creates Cancer-Fighting Cells Inside Patients

FDA Clears Trial for Next-Gen CAR-T Therapy That Creates Cancer-Fighting Cells Inside Patients

CAR-T therapy for blood cancers conventionally involves removing a patient’s immune cells, modifying them in a...
Boryung Completes Enrollment for Next-Gen Blood Cancer Drug Trial

Boryung Completes Enrollment for Next-Gen Blood Cancer Drug Trial

Boryung announced on the 19th that it has completed patient enrollment for the Phase 2 clinical trial of its...
Kang Dae-hee:

Kang Dae-hee: "Asia's Medical Infrastructure Fails to Keep Pace with Rapid Economic Growth... Telemedicine is the Answer"

“Asian economies are growing rapidly, but they are struggling to build out healthcare infrastructure.
Daewoong Pharmaceutical to Build Aseptic Manufacturing Facility for Semaglutide Microneedle Patch

Daewoong Pharmaceutical to Build Aseptic Manufacturing Facility for Semaglutide Microneedle Patch

Daewoong Pharmaceutical is accelerating efforts to secure Good Manufacturing Practice approval and establish an...
Lexraza Developer and Lilly Obesity Chief to Headline Global Clinical Trial Summit in Seoul

Lexraza Developer and Lilly Obesity Chief to Headline Global Clinical Trial Summit in Seoul

What will it take to build on the success of Lexraza, South Korea’s landmark lung cancer drug, and propel it into the...
Hanmi’s ‘Epe’ Wins MFDS Approval, Becoming South Korea’s First Homegrown GLP-1 Obesity Drug

Hanmi’s ‘Epe’ Wins MFDS Approval, Becoming South Korea’s First Homegrown GLP-1 Obesity Drug

A domestically developed therapy has entered South Korea’s obesity treatment market, long dominated by imported...
From Returned Candidate to Homegrown Breakthrough: Hanmi’s ‘Epe’ Prepares to Challenge Wegovy and Mounjaro

From Returned Candidate to Homegrown Breakthrough: Hanmi’s ‘Epe’ Prepares to Challenge Wegovy and Mounjaro

Efpeglenatide, a drug candidate whose development rights were once returned by a global pharmaceutical giant, is...